Diurnal is now Neurocrine UK

Information on Efmody® (hydrocortisone modified-release hard capsules) for Patients

Direct Markets

Information for Italian Patients on Efmody

Information for Austrian Patients on Efmody

Information for German Patients on Efmody

Partnerships

Neurocrine UK works with a number of partners in countries where it does not market its products directly.

PartnersType of contract and productPartner Territories
alt-textFrostPharmaMarketing and distribution agreement for EfmodyNordics
alt-textConsilient Health / Goodlife PharmaMarketing and distribution agreement for EfmodyNetherlands
alt-textEr-KimMarketing and distribution agreement for EfmodyBulgaria, Romania, Greece & Turkey
alt-textMedomieMarketing and distribution agreement for EfmodyIsrael
alt-textExCEEd OrphanMarketing and distribution agreement for EfmodyCroatia

Information for Czech Patients on Efmody

Neurocrine Group Ltd (Company Number: 09846650) and its subsidiary, Neurocrine UK Ltd (Company Number: 05237326) are companies registered in England and Wales. Registered Offices: Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, UK.